SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-221586
Filing Date
2023-08-25
Accepted
2023-08-25 17:01:33
Documents
12
Period of Report
2023-08-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d530547d8k.htm   iXBRL 8-K 27033
  Complete submission text file 0001193125-23-221586.txt   153413

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA dsgn-20230825.xsd EX-101.SCH 2854
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE dsgn-20230825_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dsgn-20230825_pre.xml EX-101.PRE 11710
6 EXTRACTED XBRL INSTANCE DOCUMENT d530547d8k_htm.xml XML 3475
Mailing Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011
Business Address 6005 HIDDEN VALLEY ROAD SUITE 110 CARLSBAD CA 92011 858-293-4900
Design Therapeutics, Inc. (Filer) CIK: 0001807120 (see all company filings)

IRS No.: 823929248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40288 | Film No.: 231209153
SIC: 2834 Pharmaceutical Preparations